Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Pharmazie ; 74(1): 15-17, 2019 01 01.
Article de Anglais | MEDLINE | ID: mdl-30782244

RÉSUMÉ

Diarrhea is one of the most important causes of mortality in the developing world, being responsible for 2.5 million deaths each year. Many of these deaths are caused by enterotoxigenic strains of bacteria, like Escherichia coli, that produce enterotoxins that cause acute watery diarrhea, commonly defined as secretory diarrhea. Studies on symptomatic patients indicate a high prevalence of enterotoxigenic E. coli strains producing the heat-stable toxin, STa. STa is a small, cysteine-rich peptide that binds to the extracellular receptor domain of guanylyl cyclase C (GCC), located at the luminal membrane of intestinal epithelial cells. GCC and its endogenous peptide ligands, guanylin and uroguanylin, play a key role in balancing water absorption and hydration of the intestinal lumen, as exemplified by the finding that loss of GCC function causes severe dehydration of the intestinal lumen, culminating in intestinal obstruction. From a mechanistic viewpoint, reduction of GCC activity offers an efficient approach to limit enterotoxigenic E. coli- provoked secretory diarrhea. Inhibition of GCC-mediated cGMP production would not only reduce anion secretion, but would also restore NHE3 activity, resulting in a comprehensive antidiarrheal action. In the present study, two novel phenylpyrimidinone derivatives were simultaneously synthesized and tested for their ability to block STa-induced CFTR activity in T84 cells.


Sujet(s)
Protéine CFTR/métabolisme , Antienzymes/pharmacologie , Pyrimidinones/pharmacologie , Récepteurs des entérotoxines/antagonistes et inhibiteurs , Toxines bactériennes/métabolisme , Lignée cellulaire , Diarrhée/microbiologie , Diarrhée/prévention et contrôle , Entérotoxines/métabolisme , Entérotoxines/toxicité , Antienzymes/synthèse chimique , Antienzymes/composition chimique , Protéines Escherichia coli/métabolisme , Hormones gastrointestinales/métabolisme , Humains , Muqueuse intestinale/métabolisme , Peptides natriurétiques/métabolisme , Pyrimidinones/synthèse chimique , Pyrimidinones/composition chimique , Récepteurs des entérotoxines/métabolisme
2.
Pharmazie ; 64(9): 555-64, 2009 Sep.
Article de Anglais | MEDLINE | ID: mdl-19827295

RÉSUMÉ

A series of 4-substituted piperazine derivatives bearing a norbornene nucleus have been prepared and their affinity for serotonin 5-HT1A, 5-HT2A and 5-HT2C receptors has been evaluated. Compounds showing the highest affinity have been selected and evaluated on dopaminergic (D1 and D2) and adrenergic (alpha1 and alpha2) receptors. The combination of structural elements (heterocyclic nucleus, oxyalkyl chain and 4-substituted piperazine) known to be critical in order to have affinity on serotonin receptors and the proper selection of substituents led to compounds with higher receptor specificity and affinity. In binding studies, several molecules showed affinity in nanomolar range towards 5-HT1A, 5-HT2A and 5-HT2C receptors and moderate to no affinity for other relevant receptors (D1, D2, alpha1 and alpha2). Compound 2q 4-[2-[4-(3,4-dichlorophenyl)piperazin-1-yl]ethoxy]-4-aza-tricyclo[5.2.1.02,6]dec-8-ene-3,5-dione (Ki = 1.13 nM), was the most active and selective derivative for the 5-HT2C receptor with respect to other serotonin, dopaminergic and adrenergic receptors. Moreover, compound 3p showed mixed 5-HT2A/5-HT2C activity with affinity values in nanomolar range.


Sujet(s)
Monoterpènes de type norbornane/synthèse chimique , Monoterpènes de type norbornane/pharmacologie , Récepteur de la sérotonine de type 5-HT1A/effets des médicaments et des substances chimiques , Récepteur de la sérotonine de type 5-HT2A/effets des médicaments et des substances chimiques , Récepteur de la sérotonine de type 5-HT2C/effets des médicaments et des substances chimiques , Agents sérotoninergiques/synthèse chimique , Agents sérotoninergiques/pharmacologie , Animaux , Chimie du cerveau/effets des médicaments et des substances chimiques , Ligands , Spectroscopie par résonance magnétique , Mâle , Dosage par compétition , Rats , Rat Sprague-Dawley , Récepteur de la sérotonine de type 5-HT1A/composition chimique , Récepteur de la sérotonine de type 5-HT2A/composition chimique , Récepteur de la sérotonine de type 5-HT2C/composition chimique , Récepteurs alpha-1 adrénergiques/effets des médicaments et des substances chimiques , Récepteurs alpha-1 adrénergiques/métabolisme , Récepteurs alpha-2 adrénergiques/effets des médicaments et des substances chimiques , Récepteurs alpha-2 adrénergiques/métabolisme , Récepteur dopamine D1/composition chimique , Récepteur dopamine D1/métabolisme , Récepteur D2 de la dopamine/composition chimique , Récepteur D2 de la dopamine/métabolisme
3.
IEEE Trans Image Process ; 10(4): 543-53, 2001.
Article de Anglais | MEDLINE | ID: mdl-18249644

RÉSUMÉ

We propose an on-board selection scheme for aerial and space images, based on linear feature detection in a feature hyperspace. The detection task is performed by means of the Radon transform (RT) and the wavelet transform; a fast algorithm for the RT computation is described, and counteractions against the discretization errors are proposed. A new, wavelet-based algorithm is introduced, which performs a fine analysis of the waveforms of the RT peaks, yielding a possibly error-free detection in images corrupted by a high level of noise. A technique, based on the feature hyperspace, is proposed, able to significantly exploit all the available pieces of information on these peaks. Results of the tests on synthetic and real images are reported, which show that this method achieves satisfactory results, making the detection task highly reliable in the presence of both noise and clutter.

SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE